selected publications
-
academic article
-
MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.
Mayo Clinic Proceedings.
93.
2018
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.
JAMA Oncology.
3.
2017
History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium.
Cancer Epidemiology Biomarkers & Prevention.
26.
2017
History of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.
Cancer Causes & Control.
28.
2017
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Nature Genetics.
49.
2017
Predictors of pretreatment CA125 at ovarian cancer diagnosis: a pooled analysis in the Ovarian Cancer Association Consortium.
Cancer Causes & Control.
28.
2017
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.
British Journal of Cancer.
111.
2014
Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry.
Histopathology.
64.
2014
-
hide from search
-
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
Nature Communications.
2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
The Lancet Oncology.
2013
Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.
BMC Cancer.
2013